Papers in Cancer Drug Resistance
Page 3 · newest first
- Breast cancer cell resistance to hormonal and targeted therapeutics is correlated with the inactivation of the NR6A1 axisCancer Drug Resistance · 2024
- Mechanism of ferroptosis resistance in cancer cellsCancer Drug Resistance · 2024
- HDAC-driven mechanisms in anticancer resistance: epigenetics and beyondCancer Drug Resistance · 2024
- Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunityCancer Drug Resistance · 2024
- Fra-1 affects chemotherapy sensitivity by inhibiting ferroptosis in gastric cancer cellsCancer Drug Resistance · 2024
- The role and clinical applications of exosomes in cancer drug resistanceCancer Drug Resistance · 2024
- Exploring resistance to immune checkpoint inhibitors and targeted therapies in melanomaCancer Drug Resistance · 2024
- NFE2L2 and ferroptosis resistance in cancer therapyCancer Drug Resistance · 2024
- The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer modelsCancer Drug Resistance · 2024
- Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategiesCancer Drug Resistance · 2024
- Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancersCancer Drug Resistance · 2024
- Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapyCancer Drug Resistance · 2024
- Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions in vitroCancer Drug Resistance · 2024
- Intercellular transfer of multidrug resistance mediated by extracellular vesiclesCancer Drug Resistance · 2024
- Non-coding RNA and drug resistance in head and neck cancerCancer Drug Resistance · 2024
- Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatmentCancer Drug Resistance · 2024
- Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancerCancer Drug Resistance · 2024
- Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinomaCancer Drug Resistance · 2024
- The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancerCancer Drug Resistance · 2024
- The uniqueness of ABCB5 as a full transporter ABCB5FL and a half-transporter-like ABCB5βCancer Drug Resistance · 2024
- Targeting NETosis: nature’s alarm system in cancer progressionCancer Drug Resistance · 2024
- Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapyCancer Drug Resistance · 2024
- Unraveling the complexity of drug resistance mechanisms to SINE, T cell-engaging therapies and CELMoDs in multiple myeloma: a comprehensive reviewCancer Drug Resistance · 2024
- Inhibition of glutaminolysis alone and in combination with HDAC inhibitor has anti-myeloma therapeutic effectsCancer Drug Resistance · 2024
- Recent advanced lipid-based nanomedicines for overcoming cancer resistanceCancer Drug Resistance · 2024
- The evolving role of immune checkpoint inhibitors in cervical and endometrial cancerCancer Drug Resistance · 2024
- Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancerCancer Drug Resistance · 2024
- Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patientsCancer Drug Resistance · 2024
- ALK inhibitors in cancer: mechanisms of resistance and therapeutic management strategiesCancer Drug Resistance · 2024
- Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cellsCancer Drug Resistance · 2024
- Advancing CAR T-cell therapy for chronic lymphocytic leukemia: exploring resistance mechanisms and the innovative strategies to overcome themCancer Drug Resistance · 2024
- Current knowledge about immunotherapy resistance for melanoma and potential predictive and prognostic biomarkersCancer Drug Resistance · 2024
- Isocucurbitacin B inhibits glioma growth through PI3K/AKT pathways and increases glioma sensitivity to TMZ by inhibiting hsa-mir-1286aCancer Drug Resistance · 2024
- Emerging role of MYB transcription factors in cancer drug resistanceCancer Drug Resistance · 2024
- HER3-targeted therapy: the mechanism of drug resistance and the development of anticancer drugsCancer Drug Resistance · 2024
- The therapeutic potential of circular RNA in triple-negative breast cancerCancer Drug Resistance · 2024
- Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cellsCancer Drug Resistance · 2024
- Dysregulation of calcium homeostasis in cancer and its role in chemoresistanceCancer Drug Resistance · 2024
- Overcoming immuno-resistance by rescheduling anti-VEGF/cytotoxics/anti-PD-1 combination in lung cancer modelCancer Drug Resistance · 2024
- Circular RNA circNCOA3 promotes tumor progression and anti-PD-1 resistance in colorectal cancerCancer Drug Resistance · 2024
- Regulation of Nrf2/Keap1 signaling pathway in cancer drug resistance by galectin-1: cellular and molecular implicationsCancer Drug Resistance · 2024
- Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptorsCancer Drug Resistance · 2024
- Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemiaCancer Drug Resistance · 2024
- Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemiaCancer Drug Resistance · 2024
- Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancerCancer Drug Resistance · 2024
- Ritonavir reverses resistance to docetaxel and cabazitaxel in prostate cancer cells with acquired resistance to docetaxelCancer Drug Resistance · 2024
- Targeting T regulatory (Treg) cells in immunotherapy-resistant cancersCancer Drug Resistance · 2024
- Acquisition of drug resistance in endothelial cells by tumor-derived extracellular vesicles and cancer progressionCancer Drug Resistance · 2024
- Mechanisms of tyrosine kinase inhibitor resistance in renal cell carcinomaCancer Drug Resistance · 2023
- Autophagy-related mechanisms for treatment of multiple myelomaCancer Drug Resistance · 2023